Hong NJ, Garvin JL. NADPH oxidase 4 mediates flow-induced superoxide production in thick ascending limbs.
Ϫ
was 81 Ϯ 5 AU/s in Nox2 knockout mice compared with 83 Ϯ 13 AU/s in wild-type mice. In TALs transduced with Nox1 siRNA, flow-induced O 2 Ϫ was 82 Ϯ 7 AU/s. We conclude that Nox4 mediates flow-induced O 2 Ϫ production in TALs.
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) regulates renal function (51, 58) . This reactive oxygen species (ROS) favors salt and water retention and has been implicated in salt-sensitive hypertension (23, 30, 49) . The thick ascending limb of the loop of Henle (TAL) is the main source of medullary O 2 Ϫ (28, 29, 58) , and O 2 Ϫ stimulates NaCl reabsorption in this segment (21, 34, 48) . The TAL regulates urinary volume and sodium excretion. Therefore, factors that affect TAL function may lead to inappropriate NaCl retention and result in salt-sensitive hypertension (20, 22, 41) .
Flow of urine as it forms along the nephron is highly variable (8, 43) . Luminal flow through the TAL normally varies from 0 to 20 nl/min (8, 42, 43) . Acute variations in luminal flow are a result of tubuloglomerular feedback (27) and peristalsis of the renal pelvis (8, 43) . Luminal flow also varies chronically due to volume changes (1, 42) , a high-salt diet (32) , hypertension (2, 4, 6, 40, 56) , and diabetes (38, 55) .
We found that luminal flow stimulates O 2 Ϫ production in TALs by enhancing Na-K-2Cl cotransporter activity (18) and stretching epithelial cells (12) , and we determined that the source of O 2 Ϫ is NADPH oxidase (Nox) (19) . The Nox family of superoxidegenerating enzymes consists of at least seven isoforms of the major catalytic subunit (24) . The adult kidney expresses Nox1, Nox2, and Nox4 (14) . Nox2 mRNA (14, 28) and protein (14, 54) and Nox4 protein (54) have been detected in TALs, whereas thus far Nox1 has only been found in the proximal tubules of the kidney cortex (14, 44) . Each of the three isoforms has been implicated in signaling pathways involving O 2 Ϫ stimulation in the kidney (14) . However, it is unclear which of these isoforms is involved in flow-stimulated O 2 Ϫ . Nox4 was originally named Renox because of its high expression in the kidney. We hypothesized that Nox4 is the source of O 2 Ϫ production stimulated by increases in luminal flow. To test this hypothesis, we examined the Nox isoforms expressed in TALs and used knockout animal models and adenoviral delivery of Nox isoform-specific siRNAs to determine which isoforms are involved in flow-stimulated O 2 Ϫ . Our findings indicate that 1) TALs predominantly express Nox2 and Nox4 mRNA, and to a much lower extent Nox1 mRNA; and 2) only Nox4 is involved in flow-stimulated O 2 Ϫ production.
MATERIALS AND METHODS
Chemicals and solutions. Dihydroethidium was purchased from Molecular Probes (Eugene, OR), RNeasy Plus mini kits and OneStep RT-PCR kits from Qiagen (Valencia, CA), and Nox isoform-specific PCR primers from TIB Molbiol (Adelphia, NJ). Custom oligonucleotides used to construct adenoviruses carrying Nox1-and Nox4-specific siRNA were purchased from Eurofins MWG Operon (Huntsville, AL). The composition of the physiological saline used to perfuse and bathe the TALs was (in mM) 130 NaCl, 2.5 NaH 2PO4, 4 KCl, 1.2 MgSO4, 6 L-alanine, 1 trisodium citrate, 5.5 glucose, 2 calcium dilactate, and 10 HEPES, pH 7.4 at 37°C. All solutions were adjusted to 290 Ϯ 3 mosmol/kgH 2O. Animals. Male Sprague-Dawley rats (Charles River Breeding Laboratories, Wilmington, MA) were maintained on a diet containing 0.22% sodium and 1.1% potassium (Purina, Richmond, IN) for at least 3 days. Male Nox2 knockout (Ϫ/Ϫ) and C57BL/6J wild-type mice (Jackson Laboratory, Bar Harbor, ME) were fed normal rodent chow containing 0.4% sodium. All animal protocols were approved by the Institutional Animal Care and Use Committee of Henry Ford Hospital in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
RT-PCR. Separate TAL suspensions from the adenovirus-injected left kidney and noninjected right kidney were prepared as described previously (47) . Total RNA was isolated from the suspensions using an RNeasy Plus mini kit and subsequently used for RT-PCR analysis using a OneStep RT-PCR kit according to the manufacturer's instructions. Previously published Nox isoform-specific PCR primers (50) were used to assay mRNA expression. Thermal cycler conditions for OneStep RT-PCR were 1) reverse transcription: 30 min at 50°C; 2) HotStarTaq DNA polymerase activation at 95°C for 15 min; 3) cycling at 94°C for 15 s, 60°C for 5 s, and 72°C for 1 min; and 4) final extension at 72°C for 5 min. The total number of cycles used for detection and comparison of relative abundance of Nox isoforms in rat TALs (see Fig. 2 ) was 35 cycles using 1 g RNA. However, because of the differences observed in mRNA expression among the three Nox isoforms in TALs, the number of cycles and amount of template RNA were adjusted for the purpose of evaluating knockdown of each particular Nox mRNA by an adenovirally delivered Nox isoform-specific siRNA (see Fig. 3 ). For Nox1 mRNA knockdown analysis, the PCR primers were 5=-GGAGTCCTCATTTT-GTGGGGCAACC-3= (forward) and 5=-GGCACCCGTCTCTCTA-CAAATCCAGT-3= (reverse). The total number of cycles used for Nox1, Nox2, and Nox4 was 35, 30, and 31, respectively, and the amount of RNA used was 400, 100, and 200 ng. PCR products were visualized on 1.5% agarose gels and stained with ethidium bromide (0.5 g/ml). Band densities of the expected 560-, 605-, and 409-bp amplicons for Nox1, Nox2, and Nox4, respectively, were analyzed.
Adenovirus construction. The target (sense) sequence of the siRNA against Nox4 was 5=-CCGTTTGCATCGATACTAA-3= (bases 1358 -1376 in Genbank Accession number NM_053524 for rat Nox4 mRNA). The target sequence of Nox1 siRNA (31) was 5=-AGATC-TATTTCTACTGGAT-3= (bases 1419 -1437 in Genbank Accession number NM_053683). A 63-base annealed oligonucleotide siRNA cassette containing the siRNA sequence, a 5= Afl II overhang, a 3= Spe I overhang, a transcriptional start, and termination sequence, and a hairpin loop region was inserted into the adenoviral shuttle vector pVQAdMIGHTY, which contains the H1 promoter, and sent to ViraQuest (North Liberty, IA) for adenovirus production. For the negative control, a nonsilencing sequence (Qiagen) was similarly inserted into the shuttle vector for adenovirus construction.
Adenoviral gene delivery. Rat medullary TALs (mTALs) were transduced in vivo with an adenovirus carrying a Nox4 siRNA (AdNox4siRNA), a Nox1 siRNA (AdNox1siRNA), or a nonsilencing sequence (AdscrsiRNA) as reported previously (35, 36) . The left kidney of a rat weighing 85-105 g was exposed via a flank incision and the left renal artery and vein were clamped. Four 20-l virus injections (4 ϫ 10 10 PFU/ml) at a rate of 20 l/min were made by inserting the needle perpendicular to the renal capsule, parallel to the medullary rays, and directed toward the medulla. Injection points 2.5 mm apart were selected along the longitudinal axis of the kidney. The clamp was released and the kidney was returned to the abdominal cavity. The muscle was sutured and the skin was closed with staples. mTALs were dissected 6 -7 days after injection, when maximal knockdown of Nox4 mRNA (63 Ϯ 7%; n ϭ 4, P Ͻ 0.003) was observed. For maximal Nox1 mRNA knockdown (59 Ϯ 6%; n ϭ 3, P Ͻ 0.01), a total of 100 l AdNox1siRNA was used, and TALs were dissected 8 days after injection.
Isolation and perfusion of rat TALs. On the day of the experiment, rats weighing 120 -150 g or mice weighing 20 -25 g were anesthetized with ketamine and xylazine (100 and 20 mg/kg body wt ip, respectively). After the abdominal cavity was opened, the left kidney was bathed in ice-cold saline and removed. Sagittal slices were placed in oxygenated physiological saline and mTALs were dissected from the outer medulla under a stereomicroscope at 4 -10°C. Tubules measuring 0.5-1.0 mm were transferred to a temperature-regulated chamber and perfused using concentric glass pipettes at 37 Ϯ 1°C as described previously (11) . Except for the flow rates used for Fig. 1 , we perfused tubules at a rate of 20 nl/min.
Measurement of O 2 Ϫ using dihydroethidium. Isolated TALs were loaded with 10 M dihydroethidium in physiological saline for 15 min and then washed in dye-free solution for 20 min. O 2 Ϫ converts dihydroethidium to oxyethidium (10, 57) . Oxyethidium and dihydroethidium were excited using 490-and 365-nm light, respectively. Fluorescence emitted between 520 -600 nm (oxyethidium) and 400 -450 nm (dihydroethidium) was imaged digitally with an image intensifier connected to a CCD camera and recorded with a Metafluor imaging system (Universal Imaging, West Chester, PA). Fluorescence from regions of interest was measured every 5 s for 12 measurements. Regression analysis of the fluorescence ratios for each measurement period was performed and differences in slopes were evaluated. An increased rate of change in the oxyethidium/dihydroethidium fluorescence ratio is a measure of increased net O 2 Ϫ production (production Ϫ degradation). We will refer to O 2 Ϫ measurements in this study as O 2 Ϫ production. Statistical analysis. Results are expressed as means Ϯ SE. Data were evaluated with Student's t-test, taking P Ͻ 0.05 as significant.
RESULTS

Physiological luminal flow rates stimulate O 2
Ϫ production. Physiological luminal flow rates in the TAL can vary from 0 to 20 nl/min. To characterize the relationship between flow and O 2 Ϫ production, we subjected isolated rat TALs to luminal flow rates of 0, 5, 10, and 20 nl/min and measured O 2 Ϫ production. We found it was 5 Ϯ 1 AU/s (n ϭ 6) at 0 nl/min, 9 Ϯ 2 AU/s at 5 nl/min (n ϭ 6), 36 Ϯ 6 AU/s at 10 nl/min (P Ͻ 0.0003; n ϭ 4 vs. no flow), and 66 Ϯ 8 AU/s at 20 nl/min (P Ͻ 0.0001; n ϭ 4 vs. no flow). Therefore, O 2 Ϫ production increased linearly with flow at rates 5 nl/min and above. However, O 2 Ϫ production at 5 nl/min was no different from basal no flow conditions (Fig. 1) . Whether 5 nl/ml represents an actual point at which there is no distinguishable increase in O 2 Ϫ production in response to flow or instead is due to limitations in the method of measuring O 2 Ϫ production is unclear. TALs express Nox1, Nox2, and Nox4 mRNA. To identify the Nox isoform(s) involved in flow-stimulated O 2 Ϫ , we first studied which isoforms are expressed in rat TALs by using RT-PCR. We found mRNA of each of the three isoforms in the TAL, although Nox1 was expressed far less than Nox2 or Nox4 (Fig. 2) . To demonstrate that RT-PCR could be used as a semiquantitative method, we performed a serial dilution of total RNA to generate a range of starting template from 31 to 250 ng. We found that Nox4 mRNA expression was linear to the amount of RNA template (correlation coefficient ϭ 0.9955). Additionally, because Nox1 was barely detectable in our TAL preparation, we confirmed that the Nox1 PCR primers were working properly by using them with total RNA from a VSMC cell line, in which Nox1 is highly expressed. Therefore, we can conclude that the relative abundance of the three isoforms is Nox2 Ͼ Nox4 ϾϾϾ Nox1.
In vivo transduction of TALs with adenovirus carrying Nox4 siRNA specifically and efficiently knocks down Nox4. Of the three Nox isoforms expressed in TALs, Nox4 is the most highly expressed in the kidney. Therefore, we first chose to study the role of Nox4 in flow-stimulated O 2 Ϫ production. Because there are no Nox4 Ϫ/Ϫ animal models, we transduced the outer medulla of the rat kidney in vivo with an adenovirus carrying a Nox4 siRNA (AdNox4siRNA). To establish the validity of our siRNA sequence, we transduced TALs with AdNox4siRNA and measured the effect on Nox1, Nox2, and Nox4 mRNA expression (Fig. 3) . We found that the Nox4 siRNA knocked down Nox4 mRNA in the TALs from the virus-injected left kidney by 63 Ϯ 7% (P Ͻ 0.003) compared with the noninjected right kidney, whereas it had no effect on Nox1 (16 Ϯ 7%) or Nox2 mRNA (44 Ϯ 39%). Therefore, the efficacy and specificity of the Nox4 siRNA were suitable to study the role of Nox4 in flow-induced O 2 Ϫ production.
In vivo knockdown of Nox4 inhibits flow-induced O 2
Ϫ
. Next, we examined the effect of knockdown of Nox4 on flowstimulated O 2 Ϫ . In isolated TALs transduced with a control adenovirus that contained a scrambled nonsilencing sequence (AdscrsiRNA), O 2 Ϫ production increased from 10 Ϯ 3 to 87 Ϯ 12 AU/s (⌬ ϭ 77 Ϯ 9 AU/s; P Ͻ 0.002; n ϭ 5) when subjected to flow. However, in TALs transduced with the AdNox4siRNA, flow did not significantly increase O 2 Ϫ production (7 Ϯ 2 to 25 Ϯ 9 AU/s; ⌬ ϭ 18 Ϯ 9 AU/s; n ϭ 6; Ϫ production from 19 Ϯ 7 to 102 Ϯ 20 AU/s (⌬ ϭ 83 Ϯ 13 AU/s; P Ͻ 0.03; n ϭ 3). To determine whether there are compensatory changes in Nox4 expression in Nox2 Ϫ/Ϫ mice, we compared Nox4 mRNA in wild-type and Nox2 Ϫ/Ϫ mice. We found that there was no difference. These data indicate that although Nox2 mRNA is highly expressed in TALs, it is not involved in production of O 2 Ϫ in response to luminal flow.
In vivo knockdown of Nox1 does not affect flow-induced O 2
Ϫ . In endothelial cells a "vicious cycle" in which ROS-activated Nox stimulates Nox-dependent ROS production has been proposed (7) . Therefore, it is conceivable that another source of O 2 Ϫ , such as Nox1, which is also present in TALs, could be linked to stimulation of Nox4 to cause enhanced O 2 Ϫ production. To make sure that the flow-induced increase in O 2 Ϫ derived from Nox4 is not coupled to Nox1-stimulated O 2 Ϫ , we tested rat TALs transduced with an adenovirus carrying an siRNA against Nox1 (AdNox1siRNA). The Nox1 siRNA had no effect on flow-stimulated O 2 Ϫ production (Fig. 6) . In control experiments (nontransduced TALs), flow increased O 2 Ϫ production from 7 Ϯ 2 to 98 Ϯ 14 AU/s (⌬ ϭ 91 Ϯ 13; P Ͻ 0.02). In Nox1siRNA-transduced TALs, flow stimulated O 2 Ϫ production to a similar extent (from 5 Ϯ 2 to 87 Ϯ 9 AU/s; ⌬ ϭ 82 Ϯ 7; P Ͻ 0.002). Therefore, knockdown of Nox1 did not affect flow-stimulated O 2 Ϫ production. The Nox1 siRNA knocks down Nox1 mRNA to a similar extent (59 Ϯ 6) as the Nox4 siRNA we used to knockdown Nox4 mRNA (63 Ϯ 7%). Knockdown of Nox1 siRNA does not affect Nox4 or Nox1 expression.
DISCUSSION
We demonstrated that O 2 Ϫ production increases in response to various flow rates. The flow-stimulated increases in O 2 Ϫ at these flow rates are similar to what we observed previously (18) . It appears that the break point for response to flow is approximately at 5 nl/min. O 2 Ϫ production at 5 nl/min was not significantly different than at 0 nl/min. Whether this reflects a true maximum flow rate at which O 2 Ϫ is not produced or merely a limitation of our method of measuring low O 2 Ϫ production rates is unclear. However, we estimate that the threshold for triggering O 2 Ϫ production is somewhere around 5 nl/min. Although previous studies showed that the adult kidney expresses Nox1, Nox2, and Nox4, the isoforms present and their relative abundance in specific segments of the kidney such as the TAL are not well-defined. We were able to detect in TALs the mRNA of each of the three isoforms. This is consistent with others who reported that TALs express Nox2 (14, 28, 44, 54) and Nox4 (14, 44, 54) . We also found Nox1 mRNA is present in TALs, albeit to a much lesser extent than Nox2 and Nox4. To our knowledge, we are the first to show that Nox1 mRNA is expressed in the TAL.
Relative band density can be used to deduce relative expression of each mRNA, because the same amount of RNA and number of cycles were used to detect each isoform relative to one another, and the reactions for each isoform were run together and therefore under the same conditions. Furthermore, assuming the same efficiency for each set of primers in the reverse transcription and PCR reactions and given that the PCR products are fairly similar in size, we can conclude that the relative abundance of mRNA in TALs is Nox2 Ͼ Nox4 ϾϾϾ Nox1.
We found the effect of flow on O 2 Ϫ production in TALs transduced with Nox4 siRNA was inhibited, whereas it was not affected in Nox2 Ϫ/Ϫ mice or in TALs transduced with Nox1 siRNA. These data indicate that the increase in O 2 Ϫ produced in response to increased luminal flow is derived from Nox4 and not Nox2 or Nox1. One might say that identification of Nox4 as the isoform involved in flow-mediated O 2 Ϫ was expected because Nox4, which was originally termed Renox due to its high expression in the kidney (13) , is detected in renal tubular epithelium (44) . Although high expression of an isoform does not necessarily equate to physiological importance, Nox4 activity has been reported to be determined by mRNA levels (46) .
The mechanism whereby Nox4 activity is regulated is unclear. The most characterized isoform of the NADPH oxidase family is the one found in phagocytic cells. It is composed of several subunits: 1) the major catalytic subunit (gp91 phox , also known as Nox2) and p22 phox , which are integral membrane proteins that form the flavocytochrome b 558 ; and 2) p47 phox , p67 phox , p40 phox , and the small GTPase Rac1, which reside in the cytosol until activated. In the current model of activation, a stimulus phosphorylates and activates p47 phox , which organizes the other cytosolic subunits into a complex that translocates to the membrane to allow binding to the flavocytochrome and form an active Nox (3, 25) . Nox4 is reportedly constitutively active (46) . However, our data suggest that flow acutely stimulates Nox4 activity. Our laboratory also found that angiotensin II rapidly increases O 2 Ϫ in a Nox4-dependent manner. These data are consistent with others who showed that Nox4 is acutely stimulated in proximal tubules (33) , mesangial cells (16, 17) , and cardiac fibroblasts (5) . The mechanism by which Nox4 is upregulated in the TAL rather than other Nox isoforms is unknown. The answer may lie in the differential distribution of Nox isoforms within the cell. The Nox4/p22 phox complex has been localized to the endoplasmic reticulum in endothelial cells and epithelial cell lines, whereas the flavocytochrome complex of Nox2 and Nox1 are typically found in the plasma membrane (3). Another possibility is a scheme that involves regulation of mechanosensors, because flow-induced increases in cellular stretch regulate Nox activity in many cell types, including TALs (12) and vascular cells (52) .
In endothelial cells, ROS-induced ROS production occurs in which ROS derived from one source stimulates ROS production by a different source to create a "vicious cycle" (7) . O 2 Ϫ production in TALs may also represent such a feed-forward system. We showed that flow stimulates O 2 Ϫ production via PKC-␣-mediated activation of Nox (19) . O 2 Ϫ also activates PKC-␣ (48), which can further stimulate O 2 Ϫ production. Therefore, it is conceivable that a signaling pathway exists in TALs in which Nox1 or Nox2 is activated by flow to produce O 2 Ϫ , which in turn could stimulate Nox4 to produce even more O 2 Ϫ . However, global knockout of Nox2 in the Nox2 Ϫ/Ϫ mice had no effect on flow-induced O 2 Ϫ , thus eliminating any possible involvement of Nox2. Transduction of TALs with Nox1 siRNA also had no effect on flow-induced O 2 Ϫ . Therefore, we can rule out the possibility that Nox1 may be involved in flow-stimulated O 2 Ϫ . Additionally, given that Nox1 mRNA is apparently only weakly expressed in TALs and we observed complete inhibition of flow-stimulated O 2 Ϫ in TALs transduced with the Nox4 siRNA, it is unlikely that Nox1 plays any role in flow-induced O 2 Ϫ . 
The increase in O 2
Ϫ derived from Nox and its implication in the pathophysiology of diseases such as hypertension and diabetes have been studied extensively in the vasculature (26, 37, 39, 51) . The role of Nox4 in the oxidative stress and renal damage associated with diabetes have also been reported (15, 45) . However, the effect of O 2 Ϫ in the TAL has not been as widely studied. One group showed that in type 1 diabetes PKC-dependent Nox activation increases O 2 Ϫ production and enhances Na transport (53) (54) (55) . These reports are consistent with our data that implicate the importance of Nox-derived O 2 Ϫ in conditions in which luminal flow is acutely or chronically enhanced, such as high-salt intake (9, 32), volume expansion (1, 42) , and the osmotic diuresis associated with hypertension (2, 4, 6, 40, 56) and diabetes (38, 55) .
In summary, we found that luminal flow stimulates Nox4-dependent O 2 Ϫ production by the TAL. The increased Na ϩ reabsorption caused by enhanced O 2 Ϫ in the TAL may be important in the pathogenesis of hypertension, diabetes, and other diseases associated with Na ϩ retention and chronically increased flow. Pharmacological agents that target Nox in the TAL may lead to new therapeutic approaches to treating disorders associated with oxidative stress.
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